Healthcare costs related to respiratory syncytial virus in paediatric intensive care units in the Netherlands: a nationwide prospective observational study (the BRICK study)
Open Access
- 26 June 2024
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 43, 100965
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation
This publication has 18 references indexed in Scilit:
- Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countriesVaccine, 2023
- Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trialsThe Lancet Child & Adolescent Health, 2023
- The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort studyThe Lancet Respiratory Medicine, 2022
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysisThe Lancet, 2022
- Burden of respiratory syncytial virus bronchiolitis on the Dutch pediatric intensive care unitsEuropean Journal of Pediatrics, 2021
- Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancyVaccine, 2018
- Characteristics of children admitted to intensive care with acute bronchiolitisEuropean Journal of Pediatrics, 2018
- Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infantsEuropean Journal of Pediatrics, 2017
- Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case seriesThe Lancet Global Health, 2017
- Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The NetherlandsVaccine, 2012